Directa Plus (LON:DCTA) Hits New 52-Week Low – Should You Sell?

Shares of Directa Plus Plc (LON:DCTAGet Free Report) hit a new 52-week low during trading on Tuesday . The company traded as low as GBX 6 ($0.07) and last traded at GBX 6 ($0.07), with a volume of 26024 shares traded. The stock had previously closed at GBX 6.25 ($0.08).

Directa Plus Price Performance

The firm has a market cap of £6.78 million, a price-to-earnings ratio of -108.25 and a beta of 0.74. The company’s fifty day moving average is GBX 7.17 and its 200 day moving average is GBX 12.11. The company has a quick ratio of 4.88, a current ratio of 1.50 and a debt-to-equity ratio of 57.75.

Directa Plus Company Profile

(Get Free Report)

Directa Plus has a unique and patented, chemical-free production process of pristine graphene nanoplatelets (GNPs), tailored to our partners’ and customers’ requirements. The manufacturing model is flexible and scalable. We have a pioneering vision of the applications of G+® Graphene Plus in different industrial sectors.

Further Reading

Receive News & Ratings for Directa Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Directa Plus and related companies with MarketBeat.com's FREE daily email newsletter.